OpGen Inc logo

OpGen Inc

$ 0.27 -0.0128 (-4.56%) 10:09 PM EST
P/E:
At Loss
P/B:
0.46
Market Cap:
$ 12.94M
Enterprise V:
$ 15.01M
Volume:
357.50K
Avg Vol (2M):
301.71K
Also Trade In:
Volume:
357.50K
Market Cap $:
12.94M
PE Ratio:
At Loss
Avg Vol (2-Month):
301.71K
Enterprise Value $:
15.01M
PB Ratio:
0.46
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.
Name Current Vs Industry Vs History
Cash-To-Debt 0.92
Equity-to-Asset 0.56
Debt-to-Equity 0.66
Debt-to-EBITDA -0.97
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.93
Distress
Grey
Safe
Beneish M-Score -2.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 15.48
9-Day RSI 18.98
14-Day RSI 22.94
6-1 Month Momentum % -48.04
12-1 Month Momentum % -81.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.4
Quick Ratio 1.32
Cash Ratio 1.15
Days Inventory 175.81
Days Sales Outstanding 60.51
Days Payable 142.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -375.4

Financials (Next Earnings Date:2022-11-11 Est.)

OPGN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:OPGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.102
EPS (TTM) ($) -0.79
Beta -0.46
Volatility % 68.7
14-Day RSI 22.94
14-Day ATR ($) 0.038872
20-Day SMA ($) 0.38222
12-1 Month Momentum % -81.3
52-Week Range ($) 0.2621 - 2.41
Shares Outstanding (Mil) 48.34

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

OpGen Inc Filings

Document Form Filing Date
No Filing Data

OpGen Inc Analysis

Share your research

Headlines

See More
No news.